Eden conquers US concrete market, page-14

In the upcoming quarterly (due out at the latest before the close of trading on January 31st), I expect EDE to announce that they have arranged a debt facility. IMVHO this cash will see EDE through to the end of 2020. Funding problem solved.

In the second half of 2020, I expect EDE to announce their expansion plans.

By the end of 2020 (at the very latest), I expect EDE to be cash-flow positive.

The issues of feasibility, marketability and scalability were all adressed years ago. If they were in doubt, Eden would have folded long ago and EdenCrete would now be just a distant and painful memory. According to my information, exactly the opposite is the case.

FYI: the feasibility, marketability and scalability of EdenCrete were again put under the microscope by PARCHEM in 2018. These three factors factors, as well as a host of others, were all assessed by PARCHEM as part of their due diligence. After its completion, PARCHEM were so convinced that they entered into an exclusive distribution agreement with EDE to sell EdenCrete HC and PZ in Australia and NZ.

Industry is already convinced i.e. NTPEP and AASHTO, the GDOT, the CoDOT and the Denver Public Works Department, MARTA, as well as an increasing number of other US DOT's and local readymix suppliers and contractors in Colorado, Georgia, New York etc., as well as PARCHEM in Australia.

International, as well as local institutional investors, will only take up significant positions on the EDE and TAS Top 20 share register's when EDE becomes cash-flow positive and can demonstrate a regular pipeline of significant sales i.e. institutional investors are always looking for predictable and generous returns. Asset managers are also bound by strict regulations concerning their obligations to their customers, which increasingly include pension funds. Therefore, at the current time, EDE is simply not suitable for them. Generally, institutional investors are becoming increasingly interested in investing in infrastructure and sustainabilty related companies. Therefore, IMVHO, Eden and TAS will very soon become a perfect investment vehicle for them.

Please note: Every post of mine is my own personal opinion. Every reader and/or investor must do their own research. This post, and indeed all of my posts, do not provide tax, investment, or financial advice. The information in all of my posts is presented without consideration of the investment objectives, risk tolerance or financial circumstances of potential and/or existing investors.